David S. Block, M.D., has been appointed executive vice president of international operations at DuPont Pharmaceuticals. Previously, Block served as senior vice president of business development and strategic planning. In his new role, he will have
David S. Block, M.D., has been appointed executive vice president of international operations at DuPont Pharmaceuticals. Previously, Block served as senior vice president of business development and strategic planning. In his new role, he will have responsibility for profit and loss in all regions outside the U.S. and will be charged with growing these businesses. Block joined the company in 1990 as a product development manager for central nervous system products. He is also an assistant professor of medicine at Johns Hopkins Hospital in Baltimore and a member of the active attending staff in the Moore Clinic for HIV patients.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.